Zobrazeno 1 - 10 of 369 pro vyhledávání: '"Kunishita Y"'
1
Akademický článek
Effect of Shared Decision-Making on Trust in Physicians in the Management of Systemic Lupus Erythematosus: The Trust Measurement for Physicians and Patients With Systemic Lupus Erythematosus Prospective Cohort Study.
Autor: Yoshimi R; Yokohama City University Graduate School of Medicine and Yokohama City University Hospital, Yokohama, Japan., Yajima N; Showa University School of Medicine, Tokyo, Kyoto University, Kyoto, and Fukushima Medical University, Fukushima, Japan., Hidekawa C; Yokohama City University Graduate School of Medicine, Yokohama, Japan., Sakurai N; Yokohama City University Graduate School of Medicine, Yokohama, Japan., Oguro N; Showa University School of Medicine, Tokyo, Japan., Shidahara K; Okayama University Graduate School of Medicine, Okayama, Japan., Hayashi K; Okayama University Graduate School of Medicine, Okayama, Japan., Ichikawa T; Shinshu University School of Medicine, Matsumoto, Japan., Kishida D; Shinshu University School of Medicine, Matsumoto, Japan., Miyawaki Y; Okayama University Graduate School of Medicine, Okayama, Japan., Sada KE; Okayama University Graduate School of Medicine, Okayama, and Kochi University, Nankoku, Japan., Shimojima Y; Shinshu University School of Medicine, Matsumoto, Japan., Ishikawa Y; University of Occupational and Environmental Health Japan, Kitakyushu, and Kanagawa University of Human Services, Kawasaki, Japan., Yoshioka Y; Yokohama City University Graduate School of Medicine, Yokohama, Japan., Kunishita Y; Yokohama City University Graduate School of Medicine, Yokohama, Japan., Kishimoto D; Yokohama City University Medical Center, Yokohama, Japan., Takase-Minegishi K; Yokohama City University Graduate School of Medicine, Yokohama, Japan., Kirino Y; Yokohama City University Graduate School of Medicine, Yokohama, Japan., Ohno S; Yokohama City University Medical Center, Yokohama, Japan., Kurita N; Showa University School of Medicine, Tokyo and Fukushima Medical University, Fukushima, and Fukushima Medical University Hospital, Fukushima, Japan., Nakajima H; Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Publikováno v: Arthritis care & research [Arthritis Care Res (Hoboken)] 2024 Dec; Vol. 76 (12), pp. 1597-1605. Date of Electronic Publication: 2024 Aug 29.
Zobrazit plný text záznamu
2
Akademický článek
Characteristic features of late-onset systemic lupus erythematosus: An observational study of data from the Lupus Registry of Nationwide Institutions.
Autor: Sakurai N; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Yoshimi R; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan.; Clinical Laboratory Department, Yokohama City University Hospital, Yokohama, Japan., Yajima N; Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan., Hidekawa C; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Kunishita Y; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Kishimoto D; Center for Rheumatic Diseases, Yokohama City University Medical Center, Yokohama, Japan., Sugiyama YK; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Kojitani N; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Suzuki N; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Yoshioka Y; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Komiya T; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan.; Department of Rheumatology, Yokohama Minami Kyosai Hospital, Yokohama, Japan., Takase-Minegishi K; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Kirino Y; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Sada KE; Department of Clinical Epidemiology, Kochi Medical School, Kochi University, Nankoku, Japan., Miyawaki Y; Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan., Ichinose K; Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan., Ohno S; Center for Rheumatic Diseases, Yokohama City University Medical Center, Yokohama, Japan., Kajiyama H; Department of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Morohongo, Japan., Sato S; Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan., Shimojima Y; Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, Japan., Fujiwara M; Department of Rheumatology, Yokohama Rosai Hospital, Yokohama, Japan., Nakajima H; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Publikováno v: Lupus [Lupus] 2024 Oct; Vol. 33 (12), pp. 1306-1316. Date of Electronic Publication: 2024 Sep 03.
Zobrazit plný text záznamu
3
Akademický článek
Clinical and genetic features of Japanese cases of MDS associated with VEXAS syndrome.
Autor: Kunimoto H; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, 236-0004, Japan., Miura A; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, 236-0004, Japan., Maeda A; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, 236-0004, Japan., Tsuchida N; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, 236-0004, Japan.; Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.; Department of Rare Disease Genomics, Yokohama City University Hospital, Yokohama, Japan., Uchiyama Y; Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.; Department of Rare Disease Genomics, Yokohama City University Hospital, Yokohama, Japan., Kunishita Y; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, 236-0004, Japan., Nakajima Y; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, 236-0004, Japan., Takase-Minegishi K; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, 236-0004, Japan., Yoshimi R; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, 236-0004, Japan., Miyazaki T; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, 236-0004, Japan., Hagihara M; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, 236-0004, Japan., Yamazaki E; Clinical Laboratory Department, Yokohama City University Hospital, Yokohama, Japan., Kirino Y; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, 236-0004, Japan., Matsumoto N; Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Nakajima H; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, 236-0004, Japan. hnakajim@yokohama-cu.ac.jp.
Publikováno v: International journal of hematology [Int J Hematol] 2023 Oct; Vol. 118 (4), pp. 494-502. Date of Electronic Publication: 2023 Apr 17.
Zobrazit plný text záznamu
4
Akademický článek
Protective effect of hydroxychloroquine on infections in patients with systemic lupus erythematosus: an observational study using the LUNA registry.
Autor: Hidekawa C; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Yoshimi R; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan.; Clinical Laboratory Department, Yokohama City University Hospital, Yokohama, Japan., Saigusa Y; Department of Biostatistics, Yokohama City University School of Medicine, Yokohama, Japan., Tamura J; Department of Biostatistics, Yokohama City University School of Medicine, Yokohama, Japan., Kojitani N; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Suzuki N; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Sakurai N; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Yoshioka Y; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Sugiyama-Kawahara Y; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Kunishita Y; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Kishimoto D; Center for Rheumatic Diseases, Yokohama City University Medical Center, Yokohama, Japan., Higashitani K; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Sato Y; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Komiya T; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Nagai H; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Hamada N; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Maeda A; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Tsuchida N; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Hirahara L; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Soejima Y; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Takase-Minegishi K; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Kirino Y; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Yajima N; Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan., Sada KE; Department of Clinical Epidemiology, Kochi Medical School, Kochi University, Nankoku, Japan., Miyawaki Y; Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan., Ichinose K; Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan., Ohno S; Center for Rheumatic Diseases, Yokohama City University Medical Center, Yokohama, Japan., Kajiyama H; Department of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Morohongo, Japan., Sato S; Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan., Shimojima Y; Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, Japan., Fujiwara M; Department of Rheumatology, Yokohama Rosai Hospital, Yokohama, Japan., Nakajima H; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Publikováno v: Frontiers in immunology [Front Immunol] 2023 Sep 01; Vol. 14, pp. 1227403. Date of Electronic Publication: 2023 Sep 01 (Print Publication: 2023).
Zobrazit plný text záznamu
5
Akademický článek
Efficacy and safety of abatacept in patients with rheumatoid arthritis with previous malignancy.
Autor: Kunishita Y; Department of Rheumatology, Yokohama Minami Kyosai Hospital, 1-21-1 Mutsuurahigashi, Kanazawa-Ku, Yokohama, Kanagawa 236-0037, Japan.; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Ichikawa K; Department of Hematology and Clinical Immunology, Yokohama City University Hospital, Yokohama, Japan., Uzawa Y; Department of Rheumatology, Yokohama Minami Kyosai Hospital, Yokohama, Japan., Mitsuhashi M; Department of Rheumatology, Saiseikai Yokohama-Shi Nanbu Hospital, Yokohama, Japan., Yoshioka Y; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Okubo T; Department of Rheumatology, Saiseikai Yokohama-Shi Nanbu Hospital, Yokohama, Japan., Nagaoka S; Department of Rheumatology, Yokohama Minami Kyosai Hospital, Yokohama, Japan.
Publikováno v: Therapeutic advances in musculoskeletal disease [Ther Adv Musculoskelet Dis] 2023 Aug 01; Vol. 15, pp. 1759720X231186874. Date of Electronic Publication: 2023 Aug 01 (Print Publication: 2023).
Zobrazit plný text záznamu
6
Akademický článek
Immune checkpoint inhibitor-induced arthralgia is tightly associated with improved overall survival in cancer patients.
Autor: Maeda A; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Takase-Minegishi K; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Kirino Y; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Hamada N; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Kunishita Y; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Yoshimi R; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Meguro A; Department of Ophthalmology and Visual Science, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Namkoong H; Department of Infectious Diseases, Keio University School of Medicine, Tokyo, Japan., Horita N; Chemothrapy Center, Yokohama City University Hospital, Yokohama, Japan., Nakajima H; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Publikováno v: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2023 Apr 03; Vol. 62 (4), pp. 1451-1459.
Zobrazit plný text záznamu
7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
8
Report
Case Report: Tocilizumab Treatment for VEXAS Syndrome With Relapsing Polychondritis: A Single-Center, 1-Year Longitudinal Observational Study In Japan.
Autor: Kunishita Y; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Kirino Y; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Tsuchida N; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan.; Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.; Department of Rare Disease Genomics, Yokohama City University Hospital, Yokohama, Japan., Maeda A; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Sato Y; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Takase-Minegishi K; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Yoshimi R; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Nakajima H; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Publikováno v: Frontiers in immunology [Front Immunol] 2022 Jun 13; Vol. 13, pp. 901063. Date of Electronic Publication: 2022 Jun 13 (Print Publication: 2022).
Zobrazit plný text záznamu
9
Report
Tocilizumab in VEXAS relapsing polychondritis: a single-center pilot study in Japan.
Autor: Kirino Y; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan kirino@yokohama-cu.ac.jp., Takase-Minegishi K; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan., Tsuchida N; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.; Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.; Department of Rare Disease Genomics, Yokohama City University Hospital, Yokohama, Kanagawa, Japan., Hirahara L; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan., Kunishita Y; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.; Department of Rheumatology, Yokohama Minami Kyosai Hospital, Yokohama, Kanagawa, Japan., Yoshimi R; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan., Nakajima H; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
Publikováno v: Annals of the rheumatic diseases [Ann Rheum Dis] 2021 Nov; Vol. 80 (11), pp. 1501-1502. Date of Electronic Publication: 2021 Jun 21.
Zobrazit plný text záznamu
10
Akademický článek
Anti-TRIM21 antibody is associated with aberrant B-cell function and type I interferon production in systemic lupus erythematosus.
Autor: Kunishita Y; Department of Stem Cell and Immune Regulation, 26438Yokohama City University Graduate School of Medicine, Yokohama, Japan.; Department of Rheumatology, 73663Yokohama Minami Kyosai Hospital, Yokohama, Japan., Yoshimi R; Department of Stem Cell and Immune Regulation, 26438Yokohama City University Graduate School of Medicine, Yokohama, Japan., Kamiyama R; Department of Stem Cell and Immune Regulation, 26438Yokohama City University Graduate School of Medicine, Yokohama, Japan., Kishimoto D; Center for Rheumatic Diseases, Yokohama City University Medical Center, Yokohama, Japan., Komiya T; Department of Stem Cell and Immune Regulation, 26438Yokohama City University Graduate School of Medicine, Yokohama, Japan., Sakurai N; Department of Stem Cell and Immune Regulation, 26438Yokohama City University Graduate School of Medicine, Yokohama, Japan., Sugiyama Y; Department of Rheumatology, 73663Yokohama Minami Kyosai Hospital, Yokohama, Japan., Takase-Minegishi K; Department of Stem Cell and Immune Regulation, 26438Yokohama City University Graduate School of Medicine, Yokohama, Japan., Kirino Y; Department of Stem Cell and Immune Regulation, 26438Yokohama City University Graduate School of Medicine, Yokohama, Japan., Nagaoka S; Department of Rheumatology, 73663Yokohama Minami Kyosai Hospital, Yokohama, Japan., Nakajima H; Department of Stem Cell and Immune Regulation, 26438Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Publikováno v: Lupus [Lupus] 2021 Nov; Vol. 30 (13), pp. 2054-2065. Date of Electronic Publication: 2021 Sep 25.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje